Friday, July 17, 2026

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly

FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly

Despite a number of significant limitations in the available safety and efficacy data for licensure review of Moderna, Inc.’s new mRNA influenza biologic mFlusiva, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee ((VRBPAC) voted on June 18, 2026 to recommend fast-tracked licensure of the first mRNA product to target […]

FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot

FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot

An mRNA (messenger ribonucleic acid) influenza biologic developed by Moderna, Inc. is scheduled to be reviewed today by a U.S. Food and Drug Administration (FDA) advisory panel. The Vaccines and Related Biological Products Advisory Committee ((VRBPAC) will evaluate data on Moderna’s mFlusiva (formerly known as mRNA-1010) to determine if the product provides superior relative vaccine […]

Probiotic Found in Kimchi May Help Remove Microplastics from Gut

Probiotic Found in Kimchi May Help Remove Microplastics from Gut

The impact of microplastics and nanoplastics on health include systemic inflammation, oxidative stress, endocrine disruption, and even cancer. New research suggests that kimchi, a traditional Korean dish made of fermented cabbage, may help rid the body of nanoplastics.1 Researchers gave mice a specific bacteria known as Leuconostoc mesenteroides that was derived from kimchi. Their findings […]

Study Finds Ivermectin and Mebendazole Beneficial in Treating Cancer

Study Finds Ivermectin and Mebendazole Beneficial in Treating Cancer

A new peer-reviewed study on ivermectin and mebendazole as a cancer treatment has been published in the international oncology journal Anticancer Research. The study found that 84.4 percent of cancer patients taking ivermectin and mebendazole for six months reported cancer disappearance, tumor regression, or cancer stabilization.1 Described by its authors as the largest real-world human […]

New Dengue Vaccine Suspended in Brazil After Severe Adverse Event Reports

New Dengue Vaccine Suspended in Brazil After Severe Adverse Event Reports

Brazil’s Ministry of Health and the National Health Surveillance Agency (ANVISA) suspended a mass vaccination campaign using a new dengue vaccine developed by a Brazilian biomedical research center after severe adverse events, including deaths, were associated with certain batches of the vaccine. Authorities have opened an investigation into the incidents while continuing to assess the […]

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.